SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Trading Update

22 Jan 2026 07:00

RNS Number : 8614P
Ebiquity PLC
22 January 2026
Β 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of retained EU law pursuant to the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Β 

22 January 2026

Ebiquity Plc

("the Company" or "Ebiquity")

Β 

Trading Update

Β 

Ebiquity plc, a world leader in media investment analysis, provides the following trading update for the year ended 31 December 2025 ("FY25").

Β 

The Group expects to report, subject to audit, FY25 revenues of c.Β£73.4m, adjusted EBITDA of c.Β£8.1m and adjusted operating profit of c.Β£4.6m. Unaudited net debt at 31 December 2025 is expected to be approximately Β£13.1m, reflecting improved working capital management and the benefits of cost discipline initiatives implemented during the period.

Β 

The Group experienced strong commercial momentum in Q4 2025 and entered 2026 having secured three major marketing effectiveness contracts with an aggregate contract value of over Β£10 million across their three-year terms (2026-2028). In addition, the Group also secured a number of integrated service programmes in the quarter scheduled for delivery in 2026, providing improved visibility for the new financial year.

Β 

Further to the announcement of 23 September 2025 and in response to continued macroeconomic challenges in North America, the Group has now successfully implemented a programme to right-size the cost base and, following management changes in North America, the Group begins the current financial year with an improved organisational structure, strongly positioned for sustainable, profitable growth.

Β 

Outlook

The strong commercial successes at the end of Q4 2025, together with the cost saving initiatives noted above, have resulted in the Group entering 2026 with positive momentum. The Board looks ahead to FY26 with confidence and expects revenues and profits to be ahead of FY25.

Β 

Ruben Schreurs, Chief Executive Officer, commented:

"As previously announced, we have taken decisive action during 2025 to strengthen the business. Our comprehensive restructuring programme has improved operational efficiency and enabled continued investment in marketing effectiveness and media performance capabilities.Β 

Β 

"The Β£10m plus of three-year marketing effectiveness contracts secured in December demonstrates strong client demand for our integrated, independent expertise, and our continued focus on working capital management has delivered net debt performance ahead of expectations. We are well positioned to deliver sustainable, profitable growth."

Β 

Enquiries:

Β 

Ebiquity plc

Dorcas Murray, Company Secretary

Β +44 (0) 20 7650 9600

Β 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson - Corporate Finance

Β +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

Β 

Β 

AboutΒ Ebiquity plc

Β 

Ebiquity is a world leader in media investment analysis. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

Β 

Our work is driven by 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

Β 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

Β 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

Β 

For further information, please visit:Β www.ebiquity.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGZGZMGMZGVZZ
Date   Source Headline
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company
8th Mar 20077:01 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.